Diaceutics wins at Export Industry Awards
- The award is testament to the company’s innovative approach and continual growth rate, which has been 50% year-on-year over the last three years
- Its partnerships with 29 out of the world’s 30 top pharmaceutical companies were also highlighted
- The Irish Exporters Association Awards celebrate the remarkable achievements of companies in the export industry
Dublin, 21st November 2017 – Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, today announces that it won the Small & Emerging Exporter of the Year Award at the Export Industry Awards in Dublin.
The awards, organised by the Irish Exporters Association (IEA), recognise the remarkable achievements of companies working in the export industry, including Irish exporters of manufactured goods and services, and large multinational corporations.
Diaceutics bested strong competition from a broad range of industries in its category to claim the Small & Emerging Exporter of the Year award, which recognises its exceptional performance and export strategy in relation to introducing new products and services to the precision medicine market. The judges were particularly impressed with the passion and drive of the organisation coupled with its unique vision on making the promise of precision medicine a reality.
Diaceutics helps pharmaceutical companies not only understand the diagnostic testing landscape by gathering real time data from the laboratories carrying out the tests, but it also assesses the market for each drug and maximises return on investment. In order to deliver its services globally, Diaceutics exports knowledge and data. It employs, from Ireland, a group of field experts internationally, hailing from the laboratory, diagnostic and pharmaceutical industries.
The award is testament to the company’s innovative approach and consistently strong growth rate, which has been 50% year-on-year for over the last three years, as well as its increasing international influence. This is evident from its partnerships with 29 out of the 30 top pharmaceutical companies and its activities in the top 10 pharmaceutical markets – including the US, France, Germany, the UK, Italy, Spain, Brazil, China, Russia and Australia.
It comes in the same year that Diaceutics announced a multimillion-dollar partnership with a large US commercial reference laboratory and the creation of 30 jobs by the end of 2018.
Hundreds of guests at the gala event included representatives from over 25 embassies, along with award sponsors and Mary Mitchell O’Connor TD, Minister of State at the Department of Education with special responsibility for Higher Education.
Peter Keeling, Chief Executive Officer, Diaceutics, said: “We are overjoyed to have received this prestigious award and believe that it reflects the progress that the Diaceutics team has made over the past 12 years. Being recognised in this way is fantastic and the occasion itself has been brilliant.
“Moments like this keep us motivated. While we have given more than half a million patients the best possible chance of recovery by ensuring better testing and therefore better treatment, we will continue to work to bridge the gap between doctors, laboratories and pharmaceutical companies across all areas of medicine.”
Speaking at the awards ceremony, Nicola Byrne, President of the Irish Exporters Association, said: “The Export Industry Awards began in 2001 and has gained momentum year on year. The 2017 Awards has seen the biggest and most competitive year yet with more unique applications than ever before. Our independent judging panel was particularly impressed with the competitiveness of the applications and the international opportunities companies from Ireland are winning.”
Small and Emerging Exporter of the Year 2017: (L-R) Mario Rosenstock; Nicola Byrne, President, Irish Exporters Association; Ciaran Quilty, Vice President, Facebook; Peter Keeling, Chief Executive Officer, Diaceutics. Photo credit: Maxwell Photography.
Small and Emerging Exporter of the Year 2017: Nicola Byrne, President, Irish Exporters Association; Peter Keeling, Chief Executive Officer, Diaceutics; Ciaran Quilty, Vice President, Facebook. Photo credit: Maxwell Photography.
Peter Keeling, Chief Executive Officer, Diaceutics
Diaceutics is transforming an industry model by enabling pharmaceutical companies to accelerate their market penetration and achieve a better return on new drugs by helping them to radically improve their patient testing. It does this by allowing them access to real-time testing data from its worldwide laboratory network, which helps them understand and leverage the diagnostic landscape and segment physicians by their testing behavior. The company leads the top 10 global markets in its cancer-related therapy area, with a 60% market share and experience of more than 200 drug launches. Eight out of the world’s top 10 pharmaceutical companies are clients and it currently analyses 80% of testing data in the US in its selected cancer related therapy areas. The company employs the leading global group of experts from the laboratory, diagnostic and pharmaceutical industries.